Browsing Tag
neurodevelopmental disorders
2 posts
Aelis Farma’s AEF0217 enters critical Phase 2B trial—can it become the first drug for Down syndrome cognition?
Aelis Farma launches Phase 2B trial for AEF0217 in Down syndrome—could this CB1-targeting drug finally deliver a breakthrough? Read more.
Is BlinkLab (ASX:BB1) redefining autism diagnosis through smartphones? What its FDA-ready pilot study reveals
BlinkLab's smartphone autism test posts 84% accuracy in pilot study. Find out how close it is to FDA approval and what this means for AI in healthcare.